| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | -5.12% | -0.64% | -4.47% | -4.54% | — |
| 14d | 3 | +66.67% | -1.75% | +2.29% | -4.04% | -5.03% | — |
| 30d | 3 | +66.67% | -0.14% | +3.84% | -3.99% | -3.43% | — |
| 60d | 3 | +0.00% | +19.63% | +6.58% | +13.04% | +13.47% | — |
| 90d | 3 | +0.00% | +22.80% | +9.28% | +13.52% | +12.71% | — |
| 180d | 3 | +0.00% | +15.12% | +13.81% | +1.31% | -0.38% | — |
| 1y | 3 | +0.00% | +120.66% | +23.90% | +96.76% | +96.80% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 96,829 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 12,476 | — | — | 0 | May 27, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE Chief Business Officer | 7,203 | $3.58 | $25.8K | 44,928 | May 27, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 7,203 | — | — | 118,406 | May 27, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 19,679 | $31.47 | $619.4K | 25,249 | May 27, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE Chief Business Officer | 12,476 | $1.37 | $17.1K | 37,725 | May 27, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE Chief Business Officer | 12,524 | $1.37 | $17.2K | 62,773 | May 26, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 25,000 | — | — | 0 | May 26, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 12,524 | — | — | 12,476 | May 26, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE Chief Business Officer | 25,000 | $1.38 | $34.5K | 50,249 | May 26, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 37,524 | $31.49 | $1.18M | 25,249 | May 26, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 519 | $35.00 | $18.2K | 25,249 | May 22, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 30,591 | — | — | 125,609 | May 22, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASE Chief Business Officer | 30,591 | $3.58 | $109.5K | 68,046 | May 22, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 9,315 | $33.88 | $315.6K | 25,768 | May 22, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 32,963 | $33.22 | $1.10M | 35,083 | May 22, 2026 | May 27, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 1,942 | $15.62 | $30.3K | 630,238 | Jan 14, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,856 | — | — | 696,749 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,655 | — | — | 670,893 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 6,264 | $17.00 | $106.5K | 632,180 | Dec 12, 2025 | Dec 12, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 5,300 | — | — | 638,468 | Dec 11, 2025 | Dec 12, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 10,223 | $14.73 | $150.6K | 612,646 | Jun 16, 2025 | Jun 16, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 6,800 | $14.77 | $100.4K | 622,869 | Jun 13, 2025 | Jun 16, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Business Officer | 16,977 | $14.92 | $253.3K | 629,669 | Jun 12, 2025 | Jun 16, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 38,621 | — | — | 38,621 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,876 | — | — | 25,876 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 42,088 | — | — | 861,374 | Oct 2, 2024 | Oct 4, 2024 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 144,677 | — | — | 813,430 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |